My notes is that they are late by 6-9 months; but they are doing complex work in parallel (hello CNS), have brought a lot of new staff on (training) and seeking to introduce new data science methodologies (hopefully scaleable, repeatable, ML driven) to enhance the delivery platform - you can clearly see the improvements in the PMO v1.2 dose dependent outcome sensitivities.
As a fellow consultant, you can see when one is playing with the language - consultant vs project management speak - is when you introduce more open timeframes/milestone deliverables - a shift towards introducing words like “mid” ; is consultant speak for allowing a Q2-Q3 2022 time boundary.
Ann: Commencement of Larger Animal Studies for Lead Program, page-14
-
- There are more pages in this discussion • 40 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.5¢ |
Change
-0.005(4.55%) |
Mkt cap ! $489.9M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 11.0¢ | 10.5¢ | $29.56K | 278.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 1274092 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 432957 | 2 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| PYC (ASX) Chart |